Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMX3A0O)

Drug Name
US8586571, 36 Drug Info
Synonyms SCHEMBL3105846; CHEMBL3642666; VZDYQTRPYQHMNA-UHFFFAOYSA-N; BDBM106682; US8586571, 36; 3-(3-(2-tert-butylphenoxy)azetidin-1-yl)-3-oxopropanoic acid
Cross-matching ID
PubChem CID
59577090
TTD Drug ID
DMX3A0O

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Plasma retinol-binding protein (RBP4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tinlarebant DM6JYUO Stargardt disease 9B70 Phase 3 [2]
A1-10436 DM9ESPR N. A. N. A. Patented [3]
US9434727, 93 DMCJG8Z N. A. N. A. Patented [4]
US9434727, 153 DMC812I N. A. N. A. Patented [5]
US9434727, 40 DMLPWK3 N. A. N. A. Patented [6]
US8586571, 12 DMKLJ6O N. A. N. A. Patented [1]
A1-10438 DMJD1S6 N. A. N. A. Patented [3]
US8853215, 3 DMX8NLB N. A. N. A. Patented [3]
US8586571, 6 DM1N74R N. A. N. A. Patented [1]
US9434727, 120 DMIT0H3 N. A. N. A. Patented [5]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasma retinol-binding protein (RBP4) TT0C8BY RET4_HUMAN Inhibitor [1]

References

1 Heterocyclic compound. US8586571.
2 Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development. Eur J Med Chem. 2021 Dec 15;226:113856.
3 Derivatives of N-acyl-N-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes. US8853215.
4 Substituted 4-phenylpiperidines, their preparation and use. US10072016.
5 Substituted 4-phenylpiperidines, their preparation and use. US9434727.
6 Substituted 4-phenylpiperidines, their preparation and use. US9777010.